A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
about
Pharmacotherapy of heparin- induced thrombocytopenia.Treatment of heparin-induced thrombocytopenia in cardiovascular patients.Heparin-induced thrombocytopenia: treatment options and special considerations.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Heparin-induced thrombocytopenia in the pediatric population: a review of current literature
P2860
A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A new therapeutic option by su ...... openia type II: a pilot study.
@ast
A new therapeutic option by su ...... openia type II: a pilot study.
@en
A new therapeutic option by su ...... openia type II: a pilot study.
@nl
type
label
A new therapeutic option by su ...... openia type II: a pilot study.
@ast
A new therapeutic option by su ...... openia type II: a pilot study.
@en
A new therapeutic option by su ...... openia type II: a pilot study.
@nl
prefLabel
A new therapeutic option by su ...... openia type II: a pilot study.
@ast
A new therapeutic option by su ...... openia type II: a pilot study.
@en
A new therapeutic option by su ...... openia type II: a pilot study.
@nl
P2093
P1433
P1476
A new therapeutic option by su ...... openia type II: a pilot study.
@en
P2093
P304
P356
10.1016/S0049-3848(00)00253-X
P577
2000-08-01T00:00:00Z